NDAQ:NTRS) NUS Pilots First-in-Market Green Bond Reporting Tokenisation Initiative with Northern Trust and UOB ...

Under the terms of the agreement, Biohaven is responsible for the preclinical ADC generation of three Merus bispecific antibodies under mutually agreed research plans. The agreement includes two Merus ...

NDAQ:CRBU) Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today released preliminary unaudited results for the fourth quarter and full year ended December 31, 2024. The ...

If you suffered losses exceeding $100,000 in Visa between November 16, 2023 and September 23, 2024 and would like to discuss ...

If you suffered losses exceeding $50,000 in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to ...

If you suffered losses exceeding $75,000 in Nextracker between February 1, 2024 and August 1, 2024 and would like to discuss ...

NDAQ:PTVE) Bronstein, Gewirtz & Grossman, LLC Is Investigating Pactiv Evergreen Inc. (PTVE) And Encourages Shareholders to ...